How does it differ from Clenbuterol?

Both are selective β2 agonists, but Albuterol half-life is 5-6 h vs Clenbuterol 35-40 h. Albuterol has a safer accumulation profile with no documented clinical cardiac hypertrophy at normal doses. Anabolic effect is more modest.

What does WADA "monitored" status mean?

Inhaled Albuterol up to 1600 μg/24 h is permitted in anti-asthma context, provided urine concentration is <1000 ng/mL. Oral or IV use is banned. "Monitored" indicates WADA tracks use patterns and may update thresholds.

Is it really safer than Clen?

Yes, documented. Shorter half-life prevents accumulation, significantly reducing cardiotoxic long-term effects. Albuterol intoxication is extremely rare clinically even at high doses, while Clenbuterol toxicity and cardiomyopathy cases are documented (Hoffman 2008).

What is the difference between levalbuterol and racemic albuterol?

Classic Albuterol is a racemic mixture: the (R)-enantiomer is pharmacologically active (β2-receptor-affine), the (S)-enantiomer is inactive or potentially counterproductive (paradoxical bronchoconstriction concern in preclinical models). Levalbuterol (Xopenex) is pure (R)-enantiomer, showing slightly reduced heart-rate elevation and tremor at equivalent therapeutic efficacy. Due to cost, racemic Albuterol remains the global standard; Levalbuterol is mainly indicated in children or cardio-sensitive patients. In sports context the two are practically equivalent.

ApprovedFDA approved

Albuterol

Name: Albuterol
Creator: MolekulaX

FDA-approved selective β2-agonist asthma Rx (Ventolin). Shorter half-life, safer Clenbuterol alternative.

Available at

DRIADA-10% coupon: MOLEKULAX

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Related comparisons

Clenbuterol vs Albuterol

WHAT IS ALBUTEROL?

Detailed overview

Salbutamol HCl tablet (2 mg, 4 mg) – used off-label for Clenbuterol-like thermogenic and muscle-sparing cycles. Available from pharmacy (Ventolin 2 mg tablet), guaranteeing content accuracy unlike UGL products.

Mechanism

Selective β2-adrenoceptor agonist

Half-life

5-6 h (oral), 1.5-3 h (inhaled)

Onset

5-15 min (inhaled), 15-30 min (oral)

Legal status

USA: FDA Rx (Ventolin/ProAir). HU/EU: Rx (Ventolin). WADA: inhaled <1600 μg permitted.

Data console

Lab data

/lab/molecular-data.jsonLIVE
> Androgenic:Anabolic-
> AR bindingN/A
> Active half-life5-6 h
> Detection window24-72 hours urine (WADA threshold: 1000 ng/mL).
> AromatizationNot applicable – β2-agonist, NOT a steroid; no CYP19 interaction
> HepatotoxicityLow – virtually no hepatotoxicity at therapeutic doses; tremor and tachycardia are the main side effects (FDA Proventil label)

Safety

Side effects, stop signs, contraindications

Side effects · 8

Fine tremor, especially of the hands – the most common β2-agonist effect, dose-dependent and more pronounced with the oral form.
Tachycardia and palpitations with rising heart rate; at high doses arrhythmia (e.g. atrial fibrillation) may occur.
Hypokalaemia (low serum potassium): β2 activation shifts potassium into cells; can be serious at high doses or combined with diuretics or corticosteroids, and may provoke arrhythmia.
Headache, nervousness, anxiety and insomnia – central stimulant effects, milder than with clenbuterol but present despite the short half-life.
Muscle cramps (especially calves) – partly linked to hypokalaemia; taurine and magnesium supplementation may ease it.
Rapid tolerance (β2-receptor desensitisation): the acute thermogenic and bronchodilator effect fades within 1–2 weeks, encouraging dose escalation.
Oral form: more pronounced systemic effects (stronger tremor, tachycardia, insomnia) due to higher plasma levels; nausea may also occur.
Inhaled form: local throat irritation, cough, dry mouth and hoarseness; paradoxical bronchospasm is rare but requires immediate discontinuation.

Contraindications · 7

Tachyarrhythmia and severe or uncontrolled heart disease (ischaemic heart disease, severe heart failure): β2 stimulation can provoke cardiovascular strain and arrhythmia.
Concurrent non-selective beta-blocker therapy: the two mutually antagonise (the beta-blocker abolishes bronchodilation, dangerous in asthma); the combination should be avoided.
Uncorrected hypokalaemia: albuterol further lowers serum potassium, raising arrhythmia risk – extra caution with diuretics or corticosteroids.
Hyperthyroidism: increased adrenergic sensitivity amplifies tachycardia and tremor.
Concurrent MAO inhibitor or tricyclic antidepressant: risk of hypertensive crisis and severe cardiovascular effects.
Pregnancy and breastfeeding: only on clear medical indication (asthma); off-label weight-loss use in pregnancy is prohibited.
Competitive-sport off-label use: oral/intravenous albuterol is WADA-banned, and even inhaled use is allowed only below 1600 μg/24h (urine <1000 ng/mL) – exceeding it is an anti-doping violation.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Pharmacol Rev. 2012;64(3):450-504.

Pharmacology and therapeutics of bronchodilators

Cazzola M, Page CP, Calzetta L, Matera MG.

PMID: 22611179Open

Sports Med. 2011;41(1):39-57.

β2-Agonists and physical performance: a systematic review and meta-analysis of randomised controlled trials

Pluim BM, de Hon O, Staal JB et al.

PMID: 21142283Open

Int J Sports Med. 2005;26(7):518-23.

Effects of short-term salbutamol ingestion during a Wingate test

Le Panse B, Collomp K, Portier H et al.

PMID: 16195983Open

Sports Med. 2007;37(2):95-102.

Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?

Kindermann W.

PMID: 17241101Open

Sports Med. 2019;49(4):525-539.

Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects

Heuberger JAAC, Cohen AF.

PMID: 30411235Open

Med Sci Sports Exerc. 1995;27(11):1471-6.

The effects of albuterol and isokinetic exercise on the quadriceps muscle group

Caruso JF, Signorile JF, Perry AC et al.

PMID: 8587482Open

Have a question about Albuterol?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA

Updated: June 19, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.